![Chemical structure of 2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid, CAS 38194-50-2](https://api.angenesci.com/structure/3398/38194-50-2.png)
No data
No data
No data
| CAS Number | 38194-50-2 |
| Catalog Number | AG007B4T(AGN-PC-0RFVMN) |
| Chemical Name | 2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid |
| IUPAC Name | 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid |
| InChI | InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- |
| InChI Key | MLKXDPUZXIRXEP-MFOYZWKCSA-N |
| MDL Number | MFCD00599589 |
| Molecular Formula | C20H17FO3S |
| Molecular Weight | 356.4106 |
| NSC Number | 757344 |
| SMILES | FC=1C=C2C(=C(/C(/C2=CC1)=C/C1=CC=C(C=C1)S(=O)C)C)CC(=O)O |
| Synonyms | Aclin,
Apo Sulin,
Apo-Sulin,
Arthrobid,
Arthrocine,
Chibret,
Clinoril,
Copal,
Kenalin,
Klinoril,
MK 231,
MK-231,
MK231,
Novo Sundac,
Novo-Sundac,
Nu Sulindac,
Nu-Sulindac,
Sulindac,
Sulindal,
sulindac,
Clinoril,
Arthrocine,
38194-50-2,
Sulindac sulfoxide,
Sulindaco,
Sulindacum,
Mobilin,
MK 231,
Sulindacum [INN-Latin],
Sulindaco [INN-Spanish],
Aflodac,
Sulreuma,
C20H17FO3S,
CCRIS 3305,
CHEBI:9352,
(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)benzylidene)-1H-inden-3-yl)acetic acid,
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid,
(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid,
cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid,
EINECS 253-819-2,
BRN 2951842,
Algocetil,
Artribid,
Citireuma,
Clisundac,
Imbaral,
Reumofil,
Sulinol,
CHEMBL15770,
Sudac,
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-, (Z)-,
NCGC00015970-02,
Arthrobid,
Klinoril,
CAS-38194-50-2,
DSSTox_CID_3624,
2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid,
DSSTox_RID_77117,
DSSTox_GSID_23624,
(S)-Sulindac,
cis-Sulindac,
Sulindac (Clinoril),
2-[(1Z)-5-fluoro-1-[(4-methanesulfinylphenyl)methylidene]-2-methyl-1H-inden-3-yl]acetic acid,
Clinoril (TN),
Sulindac [USAN:BAN:INN:JAN],
{(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,
SR-01000075237,
Moblilin,
(Z)-2-[5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl]acetic Acid,
2-(5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylene}inden-3-yl)acetic acid,
32004-68-5,
EINECS 250-893-8,
EINECS 256-402-3,
Sulindac [USAN:USP:INN:BAN:JAN],
Tocris-1707,
AC1LU7GY,
Clinoril;Aflodac;Sulreuma,
Prestwick3_000073,
Spectrum5_001024,
Lopac-S-8139,
S 8139,
Sulindac, >=98.0%,
SCHEMBL4202,
SCHEMBL4203,
5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid,
Lopac0_001070,
BSPBio_000285,
BSPBio_002890,
MLS001056554,
SPECTRUM1500556,
Sulindac (JP17/USP/INN),
BPBio1_000315,
GTPL5425,
DTXSID4023624,
CHEBI:93811,
HMS501O03,
cMAP_000021,
MLKXDPUZXIRXEP-MFOYZWKCSA-N,
HMS1921C11,
HMS2092K15,
HMS2095O07,
HMS2231N24,
HMS3259K06,
HMS3263E22,
HMS3649P19,
HMS3678N09,
HMS3712O07,
Pharmakon1600-01500556,
HY-B0008,
Tox21_110270,
Tox21_301418,
Tox21_501070,
BDBM50012899,
BDBM50103504,
CCG-39264,
NSC757344,
s2007,
SBB058181,
AKOS015895412,
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidenyl)indene-3-acetic acid,
Tox21_110270_1,
CS-0569,
DB00605,
KS-5153,
LP01070,
NC00540,
NSC-757344,
(Z)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid,
(Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid,
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-,
IDI1_000601,
NCGC00015970-01,
NCGC00015970-03,
NCGC00015970-04,
NCGC00015970-05,
NCGC00015970-06,
NCGC00015970-07,
NCGC00015970-08,
NCGC00015970-11,
NCGC00025268-01,
NCGC00025268-02,
NCGC00025268-03,
NCGC00094349-01,
NCGC00094349-02,
NCGC00255143-01,
NCGC00261755-01,
BP-30208,
CPD000326718,
LS-81610,
SAM002554933,
SMR000326718,
SBI-0051040.P004,
Sulindac, meets USP testing specifications,
AB2000418,
RT-000169,
AB00513800,
EU-0101070,
ST24026687,
ST51015123,
SW219748-1,
U0099,
9222-EP2275420A1,
9222-EP2277565A2,
9222-EP2277566A2,
9222-EP2277567A1,
9222-EP2277568A2,
9222-EP2277569A2,
9222-EP2277570A2,
9222-EP2280008A2,
9222-EP2281815A1,
9222-EP2284166A1,
9222-EP2292280A1,
9222-EP2295055A2,
9222-EP2295409A1,
9222-EP2298764A1,
9222-EP2298765A1,
9222-EP2301933A1,
9222-EP2305640A2,
9222-EP2305652A2,
9222-EP2308872A1,
9222-EP2311453A1,
9222-EP2311827A1,
9222-EP2314585A1,
9222-EP2314590A1,
9222-EP2316829A1,
C01531,
D00120,
W-5115,
AB00052105-07,
AB00052105_08,
AB00052105_09,
J-008554,
J-012337,
SR-01000075237-2,
SR-01000075237-3,
SR-01000075237-5,
SR-01000075237-7,
BRD-A13946108-001-04-9,
BRD-A13946108-001-08-0,
SR-01000075237-13,
Sulindac, European Pharmacopoeia (EP) Reference Standard,
Sulindac, United States Pharmacopeia (USP) Reference Standard,
(Z)-2-(5-Fluoro-2-methyl-1-(4-(methylsulfinyl)-benzylidene)-1H-inden-3-yl)acetic acid,
(Z)-5-Fluoro-2-methyl-1-[(p-methylsulfinyl)benzylidene]-1H-indene-3-acetic Acid,
(Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)-phenyl]methylene]-1H-indene-3-acetic acid,
{(1z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-indene-3-yl}acetic acid,
2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylene]inden-1-yl]acetic acid,
Sulindac|(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid,
Copals,
Copal,
Sulindal,
Chibret,
Kenalin,
Aclin,
Copal resin,
Resin copal,
cowrie,
Gum copal,
Novo Sundac,
Novo-Sundac,
Nu Sulindac,
Nu-Sulindac,
Apo Sulin,
Apo-Sulin,
Copal rosin varnish,
(R)-Sulindac,
Merck Brand of Sulindac,
UNII-184SNS8VUH,
Apotex Brand of Sulindac,
Chemia Brand of Sulindac,
KendrickBrand of Sulindac,
D0Z5IU,
Novopharm Brand of Sulindac,
Nu Pharm Brand of Sulindac,
Nu-Pharm Brand of Sulindac,
Sulindac (JAN/USP/INN),
184SNS8VUH,
Alphapharm Brand of Sulindac,
MK231,
UNII-M5221THD3M,
MK-231,
Sulindac [USAN:INN:BAN:JAN],
C20-H17-F-O3-S,
EINECS 232-527-9,
Cahill May Roberts Brand of Sulindac,
CID1548887,
CS-T-42976,
Merck Sharp & Dohme Brand of Sulindac,
B2044,
Sulindac, 98%, a COX inhibitor - 1G 1g,
D013467,
9000-14-0,
cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid,
Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid,
(1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid,
(Z)-2-(3-(4-(methylsulfinyl)benzylidene)-6-fluoro-2-methyl-3H-inden-1-yl)acetic acid,
(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid,
{(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid,
{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid,
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-,
1H-Indene-3-acetic acid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (Z)-,
1H-Indene-3-aceticacid, 5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-, (1Z)-,
2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid,
2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid,
5-fluoro-2-methyl-1-[[4-(methylsulphinyl)phenyl]methylene]-1H-indene-3-acetic acid,
(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid,
(Z)-(+-)-5-fluoro-2-methyl-1-[[4-(methylsulphinyl)phenyl]methylene]-1H-indene-3-acetic acid,
[(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid,
49627-22-7,
Copals. Extractives and their physically modified derivatives. It is a product which may contain resin acids and their esters, terpenes, and oxidation or polymerization products of these terpenes. (Trachylobium or Hymenaea courbaril, Leguminosae),
|
| Complexity | 616 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Exact Mass | 356.088g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 356.411g/mol |
| Monoisotopic Mass | 356.088g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 73.6A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.4 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H301-H317-H334-H361 |
| Packing Group | Ⅲ |
| Precautionary statements | P201-P301+P310a-P405-P501a-P261-P280-P284-P304+P340-P342+P311-P301+P310 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

